Objectives: To present evidence-based recommendations for the use of antibiotics for the treatment of the most common acute respiratory infections (ARI) and the available information on the importance of this type of management.
Introduction
Acute respiratory infections (ARI) are common, cause significant morbidity and contribute significantly to the overall disease load on the community. 1 In addition to their important social impact, ARI are a frequent cause of medical care and consumption of antibiotics. 2 It is estimated that 20-40% of outpatient consultations and 12-35% of hospital admissions to general pediatric hospitals are the result of ARI. 3 In Finland, an evaluation of diagnoses made during 1 week at 30 health centers (target population 819,000 people) revealed that 74% of 7,777 consultations were the result of respiratory infections. Taking just children aged less than five years, 84% of infections were of the respiratory airways. 4 Although the incidence of ARI is greatest during the first 5 years of life, 5 these infections have also been documented as common among adolescents from 10 years onwards, progressing with substantial comorbidity of upper and lower airways. 6 In a recent study undertaken in Pakistan with children aged 2 months to 5 years, the estimated incidence of ARI was 44%. 7 Pneumonia stands out from among the other ARI, causing 2 million child deaths per year globally (20% of all child deaths). 8 Seventy percent of these deaths occurred in Africa and Southeast Asia, in which regions the incidence of pneumonia is 2 to 10 times greater (7-40% per year) than in the United States. 9 In Latin America, the evolution of mortality due to pneumonia has varied greatly between 1990 and 2000: reducing in the majority of countries, as in Chile and Uruguay, while increasing or remaining high in others, for example Bolivia, Peru and Guyana. 10 The available data indicate that estimated annual incidence in developed countries is 10 to 15 cases/1,000 children, with annual incidence of hospital admissions due to pneumonia of from 1 to 4/1,000. 11 Around 95% of children with pneumonia are given antibiotics. 12 Acute otitis media (AOM) is the most common ARI responsible for medical consultations and in these cases antibiotics are widely prescribed. 13 In a recent study undertaken in Valencia, in Spain, the incidence of AOM was for every 1,000 inhabitants. 18 While involvement of the sinuses is common in viral respiratory infections, the true incidence of bacterial sinusitis in children is unknown. It is estimated that around 10% of upper airway infections are complicated by acute bacterial sinusitis (ABS). 19 A study that evaluated the frequency of nasal congestion and daytime coughing for longer than 9 days in 1,307 children aged 1 to 5 years seen at pediatric clinics in Seattle, USA, found a point prevalence of 9.3% (95%CI 7.7%-10.9%) for ABS; excluding comorbidity with AOM, 5% of the 1,307 children received antibiotics due to ABS. 20 A Finnish multicenter study demonstrated that antibiotics are prescribed 2 to 5 times more frequently than the true incidence of ABS warrants. 21 ABS has been described as the fifth most common cause of antibiotic prescriptions. 22 
Use of antibiotics for airway infections
The majority of ARI cases, whether involving the upper airways (AOM, AT, ABS) 23 or the lower respiratory tract (pneumonia), 24 (Figure 1 ). 28 The distinction between viral and bacterial etiology in children with AT is crucial to minimizing antibiotic use. 27 The bacterial etiologic agents most common among patients with pneumonia, AOM and ABS are Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. 22, 29, 30 Among pneumonia patients the significance of bacterial etiology is due to the lethality of these agents. 31 A compilation made of studies undertaken in developed countries to investigate the etiology of pneumonia in children, using specific and noninvasive methods, showed that, for those patients where it was possible to determine etiology, the cause was viral in 69%
and bacterial in 61% of hospitalized patients, and viral in 48% and bacterial in 65% of those seen in an outpatient setting. 30 The World Health Organization (WHO) estimates that up to 1 million children under 5 years old die annually from pneumonia, meningitis or pneumococcal sepsis, and the great majority of these deaths attributed to pneumonia occurs in developing countries. 32 Despite the lack of parity in the information available on the frequency of etiologic agents among children with pneumonia in different regions around the world, S. pneumoniae is considered the most common bacterial pathogen among children aged less than 5 years. 33 In order to contain the high mortality from pneumonia in developing countries, the WHO has suggested an algorithm ( Figure 2 ) for the management of patients with ARI. This algorithm is based on easily-detected clinical signs, such as tachypnea and subcostal retraction. 34 The same algorithm has been recommended by the SBP as a strategy to rationalize the use of antibiotics in children with ARI, 35 and there is evidence that the algorithm has a substantial impact on mortality from pneumonia. 36 On the other hand, the use of this algorithm ( Figure 2 ) has resulted in a considerable number of children being incorrectly diagnosed with pneumonia (specificity 49- * Which antibiotic will be given intravenously depends on whether acute respiratory failure or systemic involvement is present.
89%). [37] [38] [39] In a case-control study conducted in Haiti, the majority of children with recurrent pneumonia diagnosed according to the WHO algorithm actually had acute asthma crises. 40 Bronchospasm crises also present with tachypnea and, for this reason, it is possible that use of the WHO algorithm occasions unnecessary antibiotic use. 41 It is important to point out that the objective of the algorithm for management of patients with ARI is to distinguish from among children with respiratory complaints, those who have lower airway (LA) involvement, with antibiotics being recommended when the LA are affected. 42 In contrast with what has been described with relation to AT, the algorithm for managing patients with pneumonia does not make any distinction between viral and bacterial etiology. This is because of the difficulty involved in establishing the etiology of pneumonia and the fact that the high mortality from pneumonia occurs in regions where there are operational limitations in terms of basic technological resources. [9] [10] The gold standard for the diagnosis of pneumonia is the detection of pulmonary infiltrates on chest X-ray. 43 Many attempts have been made to distinguish radiologically between children with pulmonary infiltrate whose etiology is exclusively viral and those whose etiology is bacterial, of which the bacterial pneumonia score (BPS) is an example. 44 This type of attempt aims to increase the rational use of antibiotics, reducing their unnecessary utilization. Nevertheless, a
Finnish study, using specific and noninvasive methods to determine pneumonia etiology in children, demonstrated that bacterial infections can present both alveolar infiltration and interstitial infiltrate. 45 A Brazilian study has shown that X-ray findings can be influenced by the age of the child involved, possibly as a result of the differences in the inflammatory response of infants when compared with older children. 46 Therefore, the presence of radiological signs such as consolidation, pleural fluid and pneumatocele can be seen as having an association with bacterial etiology, but the absence of these signs does not signify that etiology is not bacterial. 45 The importance of antibiotic therapy for patients with AOM is related to the complications and sequelae that may take hold if etiology is bacterial. Mastoiditis and conductive deafness are two examples. 47 The introduction of antibiotics during the 1930s and 1940s led to a significant decline in the incidence, both of complications and of sequelae. 48 Nevertheless Figure 3 ). 57 It is important to point out that these recommendations emphasize the need to increase diagnostic precision when assessing patients with symptoms compatible with AOM and strongly favor the conservative treatment option, i.e., observation without introduction of a n t
i b i o t i c s , w i t h s y m p t o m a t i c m e d i c a t i o n i n uncomplicated cases of AOM. These recommendations
are innovative in that they propose a rethink of the routine use of antibiotics for patients with AOM, in the expectation that this will prevent the continuing increase of bacterial resistance, 58 without failing to treat those cases that would in fact benefit from antibiotics.
There is less evidence-based information available on the subject of patients with ABS than on the conditions described so far. 59 
Recent studies carried out in Scandinavian countries
have demonstrated that antibiotics are prescribed 2 to 5 times more than the true incidence of ABS (10%). 21 Physicians feel under pressure to prescribe antibiotics for ABS, both because of patient expectations and because of the difficulty in precisely diagnosing ABS. 61 Although it is difficult to define the precise moment when viral infections become less likely than bacterial ones, the risk of bacterial infection is greater, the longer symptoms last. 62 drugs was significantly more common among strains resistant than among strains susceptible to penicillin. 63 Of the H. influenzae strains, 28.6% were beta-lactamase producers, 70.2% were susceptible to amoxicillin, 99.8%
to a combination of amoxicillin/clavulanic acid, 82.8%
to cefuroxime axetil, 78.1% to trimethoprimsulfamethoxazole, 23.2% to cefprozil and 5% to cefaclor, azithromycin and clarithromycin. 63 Almost all strains of M. catarrhalis were resistant to amoxycillin, cefaclor, cefprozil and trimethoprim-sulfamethoxazole, and betalactamase production was the mechanism of resistance. 63 Although antibiotic resistance has been spreading over recent years, there is great variation between different locations that have been studied, with high and low penicillin resistance rates being reported in nearby geographical regions. 64 This is a very worrying situation, in view of the great ease of transport nowadays, meaning that the movement of people between different areas can rapidly contribute to the dissemination of resistant strains. 65 In Brazil, national surveillance data record that, from 1993 to 2004, the frequency of S. pneumoniae strains resistant to penicillin grew from 10.2% to 27.9%. 66 Proportions of intermediate and high levels resistance were 9.1% and Evidence that the use of antibiotics is a factor linked to the antibiotic resistance of respiratory pathogens
The respiratory pathogens commented on here are part of the flora that colonize the upper airways and as such are frequently exposed to antibiotics. 71 Patients previously exposed to the use of antibiotics have higher incidence of non-susceptible strains than patients who have not previously received antibiotics. 72 Nowadays, bacterial resistance is not only a problem in nosocomial infections, but also in community-acquired infections. 52 The majority of antibiotics consumed are used to treat community infections and the principal selective pressure to generate changes to the frequency of resistance is the volume of antibiotics consumed. 73 What has become known as antibiotic pressure is the raw relationship between the quantities of drugs employed and the selection of resistant strains. 74 In the United States, 160 million antibiotic prescriptions are filled every year, corresponding to 22.7 million kg, 50% for human consumption and 50%
for use on animals, in agriculture and fisheries. 75 For a population of 275 million people, this is the equivalent of 30 prescriptions for every 100 people and 4.1 kg of antibiotics for every 100 people annually. 74 Antibiotic pressure is different for each drug. 64 In Spain, Garcia-Rey et al. studied 1,684 strains of S.
pneumoniae isolated from patients with communityacquired respiratory infections and demonstrated that the correlation between the use of antibiotics and bacterial resistance was ascending when penicillins, cephalosporins and macrolides were analyzed separately. 76 Three important measurements can be used to predict the level of bacterial resistance at a given location: the proportion of organisms introduced from elsewhere, the proportion selected spontaneously or by antibiotic pressure and the These data allow us to suppose that, in the short term, the principal impact factor for the reduction of bacterial resistance will be the reduction of circulation of bacteria in the community. The technical difficulties involved in producing vaccines for all bacteria that cause community respiratory infections are a strong reason for compliance, in clinical practice, with these recommendations for the rational use of antibiotics.
Final comments
Bacterial resistance among respiratory pathogens is recognized as a growing problem and one of great relevance. The use of antibiotics for ARI is one of the factors that influence the occurrence of this phenomenon.
While reduction in antibiotic use doesnt appear to be associated with reductions in bacterial resistance over the short term, one of the easiest measures to implement, in the expectation of, at least, reducing the accelerated increase in resistance rates, is the rational use of antibiotics.
